EUVIMEDEUVIMED entdecken
Open Access

A conserved transcription factor regulatory program promotes tendon fate

Xubo Niu, Delmy L Melendez, Suyash Raj, Junming Cai, Dulanjalee Senadeera, Joseph Mandelbaum, Ilya A Shestopalov, Scott D Martin, Leonard I Zon, Thorsten M Schlaeger, Lick Pui Lai, Andrew P McMahon und 2 weitere

Developmental Cell · 2024

DOI: 10.1016/j.devcel.2024.08.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Developmental Cell, 2024. Verfasst von Xubo Niu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Regenerative Medicine, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Hauptthemen laut MEDLINE: Zebrafish, Tendons, Zebrafish Proteins, Transcription Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NICHD NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZebrafishTendonsZebrafish ProteinsTranscription FactorsCyclic AMP Response Element-Binding ProteinCell DifferentiationAnimalsHumansMiceGene Expression Regulation, DevelopmentalColforsinCyclic AMPPluripotent Stem CellsEnhancer Elements, Genetic

Stichwörter der Autor:innen

Creb1a/CREB1Ebf1a/Ebf3a/EBF1cAMPchemical screenenhancerforskolin/colforsinscxatendonzebrafish

Substanzen

Zebrafish ProteinsTranscription FactorsCyclic AMP Response Element-Binding ProteinColforsinCyclic AMP

Autor:innen und Institutionen

  • Center for Regenerative Medicine, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
  • Department of Orthopaedic Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Department of Sports Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Howard Hughes Medical Institute, Boston, MA, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA.
  • Department of Stem Cell Biology and Regenerative Medicine, Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033,…

Förderung

  • NIDCR NIH HHS
  • NICHD NIH HHS
  • NIAMS NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Harvard University
  • National Institutes of Health
  • Harvard Stem Cell Institute
  • Arthritis National Research Foundation

Zitieren

APA

Niu, X., Melendez, D. L., Raj, S., Cai, J., Senadeera, D., Mandelbaum, J., Shestopalov, I. A., Martin, S. D., Zon, L. I., Schlaeger, T. M., Lai, L. P., McMahon, A. P., Craft, A. M., & Galloway, J. L. (2024). A conserved transcription factor regulatory program promotes tendon fate. Developmental Cell. https://doi.org/10.1016/j.devcel.2024.08.006

Vancouver

Niu X, Melendez DL, Raj S, Cai J, Senadeera D, Mandelbaum J, et al. A conserved transcription factor regulatory program promotes tendon fate. Developmental Cell. 2024. doi:10.1016/j.devcel.2024.08.006

BibTeX
@article{Niu2024,
  author = {Niu, Xubo and Melendez, Delmy L and Raj, Suyash and Cai, Junming and Senadeera, Dulanjalee and Mandelbaum, Joseph and Shestopalov, Ilya A and Martin, Scott D and Zon, Leonard I and Schlaeger, Thorsten M and Lai, Lick Pui and McMahon, Andrew P and Craft, April M and Galloway, Jenna L},
  title = {A conserved transcription factor regulatory program promotes tendon fate},
  journal = {Developmental Cell},
  year = {2024},
  doi = {10.1016/j.devcel.2024.08.006}
}
Kostenlos starten →